LANDOVER, Md. (AP) — Austin Ekeler was concussed in the final minute of the Washington Commanders’ loss to the Dallas Cowboys on Sunday and taken to a hospital for further evaluation. Coach Dan Quinn said he and general manager Adam Peters got to visit with Ekeler before he went to the hospital. A team spokesperson said the decision to transport Ekeler was made out of an abundance of caution. Ekeler, 29, was injured when he was tackled by Damone Clark and Nick Vigil on a kickoff return with 9 seconds left in the fourth quarter. Ekeler remained down on the field for some time being attended to by medical personnel, and players from each team knelt around him with their helmets off. Lineman Andrew Wylie was also concussed and fellow running back Brian Robinson Jr. sprained an ankle in Washington’s third consecutive defeat. Ekeler is in his first season with the Commanders after spending his first nine years in the NFL with the Los Angeles Chargers. AP NFL: https://apnews.com/hub/nfl
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biden says the US is ‘all in’ on Africa during his Angola visit meant to counter China
PNC Financial Services Group Inc. Trims Holdings in Liberty Broadband Co. (NASDAQ:LBRDK)WINNIPEG, MB , Dec. 9, 2024 /CNW/ - Building fairness for every generation means taking real action to address climate change while cutting costs—including for schools. Today, Terry Duguid , Parliamentary Secretary to the Prime Minister, was joined by Vinh Huynh , Principal of the Gordon Bell High School in Winnipeg, Manitoba , to announce significant funding for an innovative project at the school to reduce pollution, improve energy efficiency, and lower energy costs. Gordon Bell High School is receiving nearly $5 million in funding through the Green Infrastructure: Energy Efficient Buildings program to complete a retrofit that will create a comfortable, climate-resilient school environment with reduced operating costs and lower greenhouse gas emissions. The deep energy retrofit at Gordon Bell High School is targeting a 51% reduction in energy use and a 71% drop in natural gas consumption at the school. The savings in energy and natural gas consumption will also demonstrate the cost-reduction potential of building retrofit projects. A key facet of the project is the development of a Retrofit Guide, a reference which will share insights supporting the adoption of energy-saving approaches in schools across Manitoba and Canada , as well as supporting course materials at Red River College. This project is an important showcase of techniques to decarbonize our schools, which can be replicated at the more than 640 public schools in Manitoba . This investment is in line with the Government of Canada's commitments through the Framework to Build a Green Prairie Economy to deliver greater collaboration across levels of government and work more closely with Prairie partners on their priorities for a cleaner and more sustainable economy for all. Federal climate action over the past nine years is working to drive greenhouse gas pollution down while the economy grows. Canada is seizing the opportunity ahead to build a strong economy with good-paying sustainable jobs, and to ensure a healthy environment for our children and grandchildren. Quotes "I would like to congratulate Gordon Bell High School on their leadership. This is a great example of how we can address climate change while driving cost savings." – The Honourable Steven Guilbeault, Minister of Environment and Climate Change "Energy efficiency means cost savings for Canadians. At a time when we are facing challenges with affordability and climate change, projects like the deep retrofit initiative at Gordon Bell High School deliver the action needed by Canadians of all ages, at the pace and scale they are demanding. Through investments like the one announced today, the Government of Canada is saving Canadians money, creating jobs, and seizing the economic opportunities of energy-efficient buildings." – The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources " Winnipeg is a hub for green innovation and climate action. Today's announcement is a great example for students in the community and across Manitoba . Gordon Bell High School's leadership should be applauded, and I am proud that we delivered this nearly $5 million federal investment to the school, which will go a long way to reduce the school's energy costs for years ahead." – Terry Duguid, Parliamentary Secretary to the Prime Minister and Special Advisor for Water and Member of Parliament for Winnipeg South "Manitobans are seeing the impacts of climate change first-hand, and they want to know that governments and educational institutions are working together to protect the environment for our children and grandchildren. Our government applauds the Government of Canada for this significant investment to support retrofits that will reduce energy use and natural gas consumption at Gordon Bell High School, creating a comfortable, climate-resilient environment for students, staff, and everyone who visits this school in the heart of Winnipeg ." – The Honourable Tracy Schmidt, Minister of Environment and Climate Change for Manitoba , Minister responsible for Efficiency Manitoba, and Acting Minister of Education and Early Childhood Learning "Winnipeg School Division is proud to be a partner with the Government of Canada and Province of Manitoba in the Gordon Bell High School retrofit project. Through this funding, the school will receive a much-needed upgrade and become a leader in climate change mitigation and action. We are excited that Gordon Bell will be a working-learning lab that will inspire learners to take significant climate action." – Matthew Henderson, Superintendent of Schools and Chief Executive Officer of the Board, Winnipeg School Division Quick facts The Gordon Bell High School Deep Energy Retrofit project aims to reduce energy use and natural gas consumption at Gordon Bell High School through a comprehensive deep energy retrofit. The school previously received funding to conduct an engineering design study for the retrofit. Funding of $4,867,306 was provided to the Province of Manitoba , through Natural Resources Canada's Energy Efficient Buildings Program. A key outcome is the development of a Retrofit Guide, which will share insights across Manitoba and Canada , supporting replicable energy-saving approaches in schools and providing content for Red River College courses. The project is expected to demonstrate cost-reduction potential, enhance knowledge sharing, and increase adoption readiness. Buildings are Canada's third-largest emitter of greenhouse gas emissions. Nearly all building emissions—over 96%—come from space and water heating. To tackle this problem, major changes in the building sector are under way, with the potential to create hundreds of thousands of jobs and help Canadians save money on their energy bills. Retrofitting existing buildings, building green from the start, and choosing alternatives to fossil-fuel heating equipment, such as electric heat pumps, will help Canada achieve its net-zero commitments by 2050. To reach Canada's climate goals, reduce energy bills, and build up Canada's supply of energy-efficient and resilient building stock, there is a need to accelerate the retrofit of approximately 10 million buildings and construct millions of new net-zero buildings in the coming decades. Associated links Energy Efficient Buildings The Canada Green Buildings Strategy: Transforming Canada's Buildings Sector for a Net-Zero and Resilient Future The Framework to Build a Green Prairie Economy 2030 Emissions Reduction Plan: Clean Air, Strong Economy Environment and Climate Change Canada's X page Environment and Climate Change Canada's Facebook page Environment and Natural Resources in Canada's Facebook page Environment and Climate Change Canada's LinkedIn page Environment and Climate Change Canada's Instagram page SOURCE Environment and Climate Change Canada View original content: http://www.newswire.ca/en/releases/archive/December2024/09/c5900.html © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
None
CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Financial Highlights "Reflecting on 2024, Citius Oncology has achieved pivotal milestones that underscore our commitment to advancing cancer therapeutics," stated Leonard Mazur , Chairman and CEO of Citius Oncology. "The FDA's approval of LYMPHIR for the treatment of cutaneous T-cell lymphoma marks a significant advancement in providing new options for patients battling this challenging disease. It is the only targeted systemic therapy approved for CTCL patients since 2018 and the only therapy with a mechanism of action that targets the IL-2 receptor. Additionally, the successful merger forming Citius Oncology, now trading on Nasdaq under the ticker CTOR, strengthens our position in the oncology sector. We expect it to facilitate greater access to capital to fund LYMPHIR's launch and the Company's future growth. With a Phase I investigator-initiated clinical trial combining LYMPHIR with pembrolizumab demonstrating promising preliminary results, indicating potential for enhanced treatment efficacy in recurrent solid tumors, and preliminary results expected from a second investigator trial with CAR-T therapies in 2025, we remain excited about the potential of LYMPHIR as a combination immunotherapy." "These accomplishments reflect the dedication of our team and the trust of our investors. As we look ahead, we remain steadfast in our mission to develop innovative therapies that improve the lives of cancer patients worldwide," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Research and Development (R&D) Expenses R&D expenses were $4.9 million for the full year ended September 30, 2024 , compared to $4.2 million for the full year ended September 30, 2023 . The increase reflects development activities completed for the resubmission of the Biologics License Application of LYMPHIR in January 2024 , which were associated with the complete response letter remediation. General and Administrative (G&A) Expenses G&A expenses were $8.1 million for the full year ended September 30, 2024 , compared to $5.9 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-commercial and commercial launch activities of LYMPHIR including market research, marketing, distribution and drug product reimbursement from health plans and payers. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $7.5 million as compared to $2.0 million for the prior year. The primary reason for the $5.5 million increase was due to the amounts being realized over 12 months in the year ended September 30, 2024 , as compared to three months post-plan adoption in the year ended September 30, 2023 . Net loss Net loss was $21.1 million , or ($0.31) per share for the year ended September 30, 2024 , compared to a net loss of $12.7 million , or ($0.19) per share for the year ended September 30, 2023 . The $8.5 million increase in net loss was primarily due to the increase in our operating expenses. About Citius Oncology, Inc. Citius Oncology specialty is a biopharmaceutical company focused on developing and commercializing novel targeted oncology therapies. In August 2024 , its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds $400 million , is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology's competitive positioning. Citius Oncology is a publicly traded subsidiary of Citius Pharmaceuticals. For more information, please visit www.citiusonc.com Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Oncology. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Oncology are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; risks related to research using our assets but conducted by third parties; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS ONCOLOGY, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 Current Assets: Cash and cash equivalents $ 112 $ — Inventory 8,268,766 — Prepaid expenses 2,700,000 7,734,895 Total Current Assets 10,968,878 7,734,895 Other Assets: In-process research and development 73,400,000 40,000,000 Total Other Assets 73,400,000 40,000,000 Total Assets $ 84,368,878 $ 47,734,895 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 3,711,622 $ 1,289,045 License payable 28,400,000 — Accrued expenses — 259,071 Due to related party 588,806 19,499,119 Total Current Liabilities 32,700,429 21,047,235 Deferred tax liability 1,728,000 1,152,000 Note payable to related party 3,800,111 — Total Liabilities 38,228,540 22,199,235 Stockholders' Equity: Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding — — Common stock - $0.0001 par value; 100,000,000; 71,552,402 and 67,500,000 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,155 6,750 Additional paid-in capital 85,411,771 43,658,750 Accumulated deficit (39,278,587) (18,129,840) Total Stockholders' Equity 46,140,339 25,535,660 Total Liabilities and Stockholders' Equity $ 84,368,878 $ 47,734,895 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 4,925,001 4,240,451 General and administrative 8,148,929 5,915,290 Stock-based compensation – general and administrative 7,498,817 1,965,500 Total Operating Expenses 20,572,747 12,121,241 Loss before Income Taxes (20,572,747) (12,121,241) Income tax expense 576,000 576,000 Net Loss $ (21,148,747) $ (12,697,241) Net Loss Per Share – Basic and Diluted $ (0.31) $ (0.19) Weighted Average Common Shares Outstanding – Basic and Diluted 68,053,607 67,500,000 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Cash Flows From Operating Activities: Net loss $ (21,148,747) $ (12,697,241) Adjustments to reconcile net loss to net cash provided by operating activities: Stock-based compensation expense 7,498,817 1,965,500 Deferred income tax expense 576,000 576,000 Changes in operating assets and liabilities: Inventory (2,133,871) - Prepaid expenses (1,100,000) (5,044,713) Accounts payable 2,422,577 1,196,734 Accrued expenses (259,071) (801,754) Due to related party 14,270,648 14,805,474 Net Cash Provided By Operating Activities 126,353 - Cash Flows From Investing Activities: License payment (5,000,000) - Net Cash Used In Investing Activities (5,000,000) - Cash Flows From Financing Activities: Cash contributed by parent 3,827,944 - Merger, net (2,754,296) - Proceeds from issuance of note payable to related party 3,800,111 - Net Cash Provided By Financing Activities 4,873,759 - Net Change in Cash and Cash Equivalents 112 - Cash and Cash Equivalents – Beginning of Year - - Cash and Cash Equivalents – End of Year $ 112 $ - Supplemental Disclosures of Cash Flow Information and Non-cash Activities: IPR&D Milestones included in License Payable $ 28,400,000 $NoneGaetz withdraws as Trump's pick for attorney general, averting confirmation battle in the Senate WASHINGTON (AP) — Matt Gaetz has withdrawn as Donald Trump’s pick for attorney general following scrutiny over a federal sex trafficking investigation. The Florida Republican made the announcement Thursday. Gaetz’s withdrawal is a blow to Trump’s push to install steadfast loyalists in his incoming administration and the first sign that Trump could face resistance from members of his own party. Trump said in a social media post that Gaetz “did not want to be a distraction for the Administration.” Gaetz said “it is clear that my confirmation was unfairly becoming a distraction to the critical work" of the transition team. He added, “There is no time to waste on a needlessly protracted Washington scuffle.” Warrants put Israeli PM and others in a small group of leaders accused of crimes against humanity Arrest warrants issued for Israeli Prime Minister Benjamin Netanyahu, his former defense minister and a Hamas leader put them in a small group of leaders to be accused of crimes against humanity. The International Criminal Court in the Hague issued the warrants Thursday for Netanyahu, his former defense minister, Yoav Gallant, and Mohammed Deif, a Hamas leader Israel claims it killed. The court says Hamas committed murder, rape and torture in the Oct. 7, 2023, attacks that triggered the Israel-Hamas war. The court also says Israel used starvation as a method of warfare and committed murder, persecution and other inhumane acts. Several of Trump's Cabinet picks — and Trump himself — have been accused of sexual misconduct WASHINGTON (AP) — Former congressman Matt Gaetz has withdrawn his name as President-elect Donald Trump's choice for attorney general in the face of sexual misconduct allegations. He's not the only member of Trump’s chosen staff and Cabinet accused of some form of misconduct. Others include: Elon Musk, his choice to help lead a new outside panel seeking to boost government efficiency, Health and Human Services nominee Robert F. Kennedy, Jr., Trump’s choice for defense secretary Pete Hegseth and Linda McMahon, his choice to lead the Department of Education. They all deny the claims. Elon Musk's budget crusade could cause a constitutional clash in Trump's second term WASHINGTON (AP) — Donald Trump has put Elon Musk and Vivek Ramaswamy in charge of finding ways to cut government spending and regulations. It's possible that their efforts will lead to a constitutional clash. This week, Musk and Ramaswamy said they would encourage the Republican president-elect to refuse to spend money allocated by Congress, which would conflict with a 1974 law that's intended to prevent presidents from blocking funds. If Trump takes such a step, it would quickly become one of the most closely watched legal battles of his second administration. Musk and Ramaswamy also aim to dramatically reduce the size of the federal workforce. Death toll in Gaza from Israel-Hamas war passes 44,000, Palestinian officials say DEIR AL-BALAH, Gaza Strip (AP) — Palestinian health officials say the death toll in the Gaza Strip from the 13-month-old war between Israel and Hamas has surpassed 44,000. The Gaza Health Ministry does not distinguish between civilians and combatants in its count, but it has said that more than half of the fatalities are women and children. The Israeli military says it has killed over 17,000 militants, without providing evidence. The war began when Hamas-led militants stormed into southern Israel on Oct. 7, 2023, killing some 1,200 people, mostly civilians, and abducting another 250. Around 100 hostages are still inside Gaza, at least a third of whom are believed to be dead. Most of the rest were released during a cease-fire last year. Putin touts Russia's new missile and delivers a menacing warning to NATO The new ballistic missile fired by Russia struck a military-industrial facility in the central Ukrainian city of Dnipro, but its real mission was delivering a deadly new message to NATO. Hours after Thursday’s strike touched off a debate over whether the Ukrainian plant was hit by an intercontinental ballistic missile, President Vladimir Putin cleared up the mystery in a rare and surprise appearance on Russian television. He described it as a new, intermediate-range ballistic missile that raced to its target at 10 times the speed of sound and couldn't be stopped by modern anti-missile systems. One Western expert said it was the first time that such a missile was used in the war — and perhaps in any conflict. What to know about a storm bringing high winds, heavy rain, snow to California and Pacific Northwest SAN FRANCISCO (AP) — One of the strongest storms on the West Coast in decades knocked out power for thousands of people and unleashed strong winds that toppled trees and left two dead in Washington before making its way through Oregon to Northern California. The storm was dumping heavy snow and record amounts of rain in the region on Thursday. The National Weather Service extended a flood watch into Saturday for areas north of San Francisco. The storm system roared ashore Tuesday and it’s expected to bring moderate to heavy rain through Saturday, increasing the risk of flash flooding and rockslides in some areas. Brazilian police indict former President Bolsonaro and aides over alleged 2022 coup attempt SAO PAULO (AP) — Brazil’s Federal Police have indicted former President Jair Bolsonaro and 36 other people on charges of attempting a coup to keep him in office after his electoral defeat in the 2022 elections. The findings are to be delivered Thursday to Brazil’s Supreme Court, which will refer them to Prosecutor-General Paulo Gonet, who will either formally charge Bolsonaro and put the former president on trial or toss the investigation. The former right-wing president has denied all claims he tried to stay in office after his narrow electoral defeat in 2022 to his rival, leftist President Luiz Inácio Lula da Silva. Bolsonaro has faced a series of legal threats since then. Jussie Smollett’s conviction in 2019 attack on himself is overturned SPRINGFIELD, Ill. (AP) — The Illinois Supreme Court has overturned actor Jussie Smollett’s conviction on charges that he staged a racist and homophobic attack against himself in 2019 and lied to Chicago police. The state’s highest court ruled Thursday on Smollett’s argument that a special prosecutor should not have been allowed to intervene after the local state’s attorney initially dropped charges. The 5-0 decision did not address Smollett's claims of innocence. The Black, gay actor claimed two men assaulted him, spouted slurs and tossed a noose around his neck. Smollett was on the television drama “Empire,” which filmed in Chicago. Testimony at his trial indicated Smollett paid $3,500 to two men to carry out the attack. US towns plunge into debates about fluoride in water NEW YORK (AP) — Fights are cropping up nationwide over fluoride in drinking water. Communities in Florida, Texas, Oregon, Utah, Wyoming and elsewhere have debated the idea in recent months. And several have decided to stop adding it to drinking water. In August, a federal agency for the first time reported that there is a link between high levels of fluoride exposure and lower IQ in kids. And in September, a federal judge ordered the U.S. Environmental Protection Agency to further regulate it in drinking water. The decision to add fluoride to drinking water rests with state and local officials, but advisers to Donald Trump have suggested he would push to remove it.
We are less than two weeks away from the start of the inaugural 12-team College Football Playoff. The playoff field was finalized on Sunday and the first game will kick off on Friday, Dec. 20. This matchup features the No. 10 Indiana Hoosiers (11-1) against the No. 7 Notre Dame Fighting Irish (11-1). With the teams now determined, analysts and fans are eager to predict which one will take home the trophy at the end of the season. The Oregon Ducks (13-0) are the No. 1 overall seed and the only undefeated team this year. However, gives them the fifth-best odds to win the championship at 9.9%. Javascript is required for you to be able to read premium content. Thanks for the feedback.
By HALELUYA HADERO, Associated Press President-elect Donald Trump asked the Supreme Court on Friday to pause the potential TikTok ban from going into effect until his administration can pursue a “political resolution” to the issue. The request came as TikTok and the Biden administration filed opposing briefs to the court, in which the company argued the court should strike down a law that could ban the platform by Jan. 19 while the government emphasized its position that the statute is needed to eliminate a national security risk. “President Trump takes no position on the underlying merits of this dispute. Instead, he respectfully requests that the Court consider staying the Act’s deadline for divestment of January 19, 2025, while it considers the merits of this case,” said Trump’s amicus brief, which supported neither party in the case. The filings come ahead of oral arguments scheduled for Jan. 10 on whether the law, which requires TikTok to divest from its China-based parent company or face a ban, unlawfully restricts speech in violation of the First Amendment. Earlier this month, a panel of three federal judges on the U.S. Court of Appeals for the District of Columbia Circuit unanimously upheld the statute , leading TikTok to appeal the case to the Supreme Court. The brief from Trump said he opposes banning TikTok at this junction and “seeks the ability to resolve the issues at hand through political means once he takes office.”H&M REOPENS ICONIC TIMES SQUARE FLAGSHIP IN NEW YORK CITY AS NEW BRAND SHOWCASE
Amazing Disney Robot Dances! See the Future of Lifelike Movement